Literature DB >> 21054832

Health related quality of life of Canary Island citizens.

Juan Oliva-Moreno1, Julio Lopez-Bastida, Melany Worbes-Cerezo, Pedro Serrano-Aguilar.   

Abstract

BACKGROUND: The aim of the study was to describe the health-related quality of life of Canarian population using information from the Canary Island Health Survey and three observational studies developed in the Canary Islands.
METHODS: A descriptive analysis was carried out on a sample of 5.549 Canarian citizens using information from 2004 Canary Island Health Survey and three observational studies on Alzheimer's disease, Stroke and HIV. EQ-5 D was the generic tool used for revealing quality of life of people surveyed. Besides the rate of people reporting moderate or severe decrease in quality of life, TTO-index scores and visual analogue scale were used for assessing health related quality of life of people that suffer a specific diseases and general population.
RESULTS: Self-perceived health status of citizens that suffer chronic diseases of high prevalence, identifies by the Canary Island Health Survey and other diseases such Alzheimer's disease, Stroke and HIV, independently examined in observational studies, are worse than self-perceived health of general population. Depression/anxiety and pain/discomfort were identified as the dimensions of the EQ-5 D with highest prevalence of problems. Alzheimer's disease and stroke were the illnesses with greater loss of quality of life.
CONCLUSIONS: Health related quality of life should be integrated into a set of information along with expectancy of life, incidence and prevalence of chronic diseases for developing health policy and planning health care activities The combination of information on health related quality of life from population health surveys with data from observational studies enlarges the sources of relevant information for setting health priorities and assessing the impact of health policies.

Entities:  

Mesh:

Year:  2010        PMID: 21054832      PMCID: PMC3091580          DOI: 10.1186/1471-2458-10-675

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

Health is one of the main determinants of the welfare of societies. Developed countries allocate a great amount of monetary and non-monetary resources to the care of their population health. Therefore, the measurement and the analysis of the evolution of the health of a population are relevant elements for health decision-makers and for the society at large. Traditionally, the health of a population has been measured using epidemiological indicators, morbidity (incidence and prevalence) and mortality [1]. Under the traditional biomedical model of the disease, the mortality rate and the life expectancy at birth or life expectancy at a given age have traditionally been used, together with the infant mortality rate, as the main indicators of populations' health. Although the concept of quality of life arose in the social science literature in 1920 [2], the World Health Organization's (WHO) 1947 definition of health as "a state of complete physical, mental and social welfare and not merely the absence of disease or infirmity" [3] encourages a new "psycho-social" model in which consideration is not only given to the "amount of life" but also to the preferences and perception on individuals about their own health, that is, their quality of life [4,5]. Health related quality of life (HRQOL) is a multi-attribute concept encompassing physical, mental, and social dimensions. In last decades, quality of life has increased in importance as a key health indicator for several reasons [1]. First of all, it has become increasingly clear that mortality reduction cannot be the only objective for health care systems facing mostly chronic and degenerative diseases. Secondly, it has also become clear that it is the patient, not the physician, who has the authority to judge his/her health status. Thirdly, the evolution of the economic evaluation methods of health care technologies has allowed and stimulated an increase in the interest in subjective health and quality of life of patients. As Sullivan notes [1], "Medicine's epidemiological transition from acute to chronic disease is thus prompting an epistemological transition from primarily objective to primarily subjective evidence of health and health care effectiveness. Now some of the most important patient outcomes, like patient choices before them, are valid because they are subjective". Additionally, several studies reveals that a worse HRQOL is associated with higher mortality [6-9] and a greater use of healthcare services [8,10,11]. Traditionally, populations' health surveys include questions on self-perceived health status, but recently generic instruments, such as the EQ-5 D, are increasingly included in these surveys for measuring HRQOL, . EQ-5 D has been used in specific groups and in the general population in several European countries, Japan, and United States of America [12-17] and is commonly used for describing the most commonly reported health states, for establishing the health status in the community, so that different population subgroups can be compared, for studying the association between HRQOL and age, sex, socio-economic status and disease groups, for analyzing efficacy in randomized clinical trials and efficiency in evaluations of health care technologies, and for examining the association between HRQOL and mortality risk. Additionally, there is a substantial amount of literature on descriptive studies on the HRQOL in the general population. However, very few studies have specifically reported HRQOL from representative samples of the general population jointly with HRQOL data from epidemiological studies focused on diseases of lower prevalence that are not usually identified by general health surveys. The aim of this study was to describe the health-related quality of life (HRQOL) of Canary Islands citizens in the first years of XXI century. For this purpose, we have combined information from the Canary Island Health Survey jointly with information from observational studies.

Methods

Our primary sources of data were the Canary Island Health Survey (CIHS) and three observational studies on HIV/AIDS, Alzheimer's disease and Stroke. The reason that led us to combine these sources was to show a map of the health status of the Canary Island population that would be impossible to collect only with the information contained in the Canary Island health survey since diseases with devastating effects on human health but with low prevalence at the population level, like HIV/AIDS, Alzheimer's disease and Stroke, are not captured adequately by general health surveys, e.g. differences between stages of the disease. The CIHS was carried out in the year 2004, with a sample of 4,320 adult people residing in Canary Islands (an insular southwest region of Spain with more than 2 millions inhabitants in 2008, the 4.5 per cent of the total population of Spain). The survey included questions on self-perceived health status, chronic morbidity, habits (including feeding, physical exercise and tobacco and alcohol consumption) and socio-demographics variables (as age, gender, educational level, occupation status). We focused our interest in the most prevalent health problems according CIHS: Diabetes mellitus, rheumatism-arthritis and degenerative osteoarthritis, back pain, heart problems, osteoporosis, anxiety/depression, respiratory and digestive diseases. The three observational studies included were carried out on behalf of the Canary Islands Health Service. The study on Alzheimer's disease (AD) was a cross-sectional observational study with a sample of 237 patients with AD. The interviewees lived in the Canary Islands and the patients were not institutionalised. The information was obtained via telephone interview on the main carer. The questionnaire was performed using a base questionnaire of the "Trans-national analysis of the socio-economic impact of AD in the European Union" Project. The "Clinical Dementia Rating" (CDR) was used for controlling the severity of the disease. This clinical score classify the severity of the disease into three levels: mild-moderate and severe. Fieldwork was carried out in 2001 [18]. The study was approved by the Ethics Research Committee of University Hospital Nuestra Sra. de la Candelaria. The observational study on HIV/AIDS was performed as a multi-centre study in the Canary Islands using a sample of 569 patients recruited at outpatient visits. The study was approved by the Ethics Research Committee of University Hospital Nuestra Sra. de la Candelaria. Demographic and clinical data were obtained from four hospitals offering HIV outpatient services in the Canary Islands. Potential participants were randomly selected from clinical records. Patients at least 18 years old were interviewed following outpatient visits at the hospitals' centres for infectious diseases. Fieldwork was carried out between January and December, 2003 [19]. The selected criteria to create the groups in the HIV research were proposed by the Center of Disease Control and Prevention (CDC). CDC distinguishes between the following phases of disease: asymptomatic HIV, symptomatic HIV and AIDS. Unfortunately, it was not possible to distinguish between different levels of severity for diagnosed diseases in the Canary Island Health Survey. The observational study on Stroke survivors was a cross-sectional study with a sample of 423 people diagnosed with stroke receiving outpatient care. Patients were recruited from five hospitals in the Canary Islands, Spain, according the year the suffered the stroke and were divided into three categories: first, second and three years survivors. The fieldwork was carried out between January and December 2004. Demographic and clinical data were collected for patients previously diagnosed with stroke or their caregivers as proxies [20]. The study was approved by the Ethics Research Committee of University Hospital Nuestra Sra. de la Candelaria. Health Related Quality Of Life (HRQOL) was measured in CIHS and the three observational studies through a generic measure, the EQ-5 D questionnaire [21.22]. The EQ-5 D has five questions asking for a self-perceived status of five different functional conditions related to mobility, personal care, daily activities, pain/discomfort and anxiety/depression. In each dimension, the interviewed person can choose between three possible answers: 'absence of problems', 'moderate problems' and 'incapacity to perform the activity or severe problems'. A respondent health status is defined by combining one level from each of the 5 dimensions (EQ-5D). A total of 243 possible health statuses can be defined in this way. HRQOL (EQ-5D) of AD patients were assessed by the patients' caregivers, as well as in the case of stroke patients with affected level of consciousness. In order to translate this number to a single health score, a 'preferences index score or tariff' is needed. Actually, there are two alternative index scores or tariffs validated in Spain, the first one based on a visual analogue scale (the VAS index score or tariff) and the second one based on the time trade-off (TTO index score or tariff [23]). The results derived from both index scores or tariffs are not directly comparable in spite of some attempts to connect them [24]. The TTO scale is frequently used, and considered a suitable alternative in the literature [25,26] because preferences are usually observed through choices between alternatives health states. The results are displayed using TTO index tariffs and the observed values in the VAS thermometer. We performed a statistical descriptive analysis. Apart from age and sex, there were no common variables in the four databases used. Due to this fact, a multivariate analysis was unfeasible. Therefore, the study described the situation of people with diagnosed diseases, but we could not analyse the associations between those illness and other health factors like education, income status, social class, habits, etc.

Results

Tables 1 and 2 show the presence of moderate-severe restrictions in different Health Related Quality of Life dimensions associated to the identified diseases, compared with the general population. Table 3 contains TTO index scores or tariffs results for people that suffer specific diseases and table 4 shows the corresponding index scores or tariffs for general population. Finally, Tables 5 and 6 display the results obtained through the visual analogue scale-thermometer for people that suffer a specific diseases and for the general population.
Table 1

Percentage of people that suffer a specific disease reporting moderate or severe problems in different Health Related Quality of Life dimensions

Average Age(sd)MobilitySelf-careUsual activitiesPain/DiscomfortDepression/Anxiety
HIV+i40.4(8.1)18.32%4.60%27.94%44.75%51.74%

 HIV-asymptomatic39.5 (7.8)15.50%4.69%23.44%42.19%49.41%

 HIV-symptomatic40.6 (8.1)14.49%5.07%28.26%41.61%46.76%

 AIDS41.8 (8.7)26.67%4.03%35.33%52.00%60.26%

Alzheimer diseaseii75.5 (8.5)68.86%84.49%95.10%68.57%73.47%

 AD mild73.7 (7.1)38.78%63.27%93.88%65.31%81.63%

 AD medium75.4 (8.6)67.03%90.11%95.60%68.13%73.63%

 AD severe76.6 (9.3)87.63%96.91%98.97%71.13%69.07%

Strokeiii66.9 (12.2)63.01%48.39%64.24%71.00%65.90%

 Stroke survivor first year67.2 (11.6)56.99%46.24%64.89%68.13%64.13%

 Stroke survivor second year67.1 (12.5)63.00%49.49%64.88%72.64%66.33%

 Stroke survivor three or more years66.4 (12.1)66.90%48.28%6.45%70.55%66.43%

Diabetes Mellitusiv63.8 (13.8)38.02%15.70%35.64%62.98%43.06%

Rheumatism; arthritis; degenerative osteoarthritisiv62.4 (14.9)41.37%14.26%33.24%71.65%46.25%

Back painiv53.8 (17.3)28.66%10.49%26.17%61.22%43.11%

Heart problemsiv66.1 (16.3)43.53%20.65%38.94%62.83%46.45%

Osteoporosisiv66.3 (12.2)46.31%19.70%37.44%75.62%55.28%

Anxiety/depression4v53.2 (17.3)29.52%10.62%28.39%64.56%70.98%

Respiratory Tract Diseasesiv54.8 (19.7)33.18%9.81%31.31%58.21%38.86%

Digestive diseasesiv52.0 (17.7)27.87%8.40%23.62%58.93%43.69%

Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey

Table 2

Canary Island General population-Percentage of people reporting moderate or severe problems in different Health Related Quality of Life dimensions

PopulationMobilitySelf-careUsual activitiesPain/DiscomfortDepression/Anxiety
General population16.18%5.63%13.19%36.38%27.03%

General population (men)13.16%4.73%10.70%27.98%17.94%

General population(women)18.20%6.27%14.97%42.36%33.52%

General populationAge 16-444.19%1.21%4.05%22.36%19.70%

General populationAge 45-6517.63%4.13%14.13%42.99%32.90%

General populationAge ≥ 6540.08%16.80%31.58%58.72%35.99%

General populationSeniors IAge 66-7435.27%10.04%24.77%56.18%34.31%

General populationSeniors IIAge 75-8445.51%22.60%36.84%63.75%38.36%

General populationSeniors IIIAge ≥ 8561.54%48.72%66.67%60.53%38.36%

Source: own elaboration from Canary Island Health Survey

Table 3

Canarian Population that suffer a specific disease.

PopulationSampleAverageStandard deviationPercentile 25%Percentile 50%Percentile 75%
HIV+i5380.8104000.24647320.7490.87711

 HIV-asymptomatic2550.82706940.23629020.78140.90951

 HIV-symptomatic1360.83752430.20750940.7490.90951

 AIDS1470.75633610.28701250.65330.86441

Alzheimer diseaseii2370.09588350.3872881-0.1530.02790.3388

 AD mild490.5248510.25014510.25580.60220.7485

 AD medium910.18176040.3133704-0.0680.10950.3388

 AD severe97-0.20137630.2349101-0.395-0.241-0.017

Strokeiii4230.47181580.43889450.06580.56980.8265

 Stroke survivor first year890.49606850.42458840.14850.61490.8265

 Stroke survivor second year1930.46960210.44070070.06070.56980.8644

 Stroke survivor three or more years1410.45960210.44747670.10950.56980.8265

Diabetes Mellitusiv3580.69347850.32702080.51920.82651

Rheumatism; arthritis; degenerative osteoarthritisiv10090.68745590.3128440.51920.79960.8771

Back painiv9970.73346930.31112580.53880.87711

Heart problemsiv3360.68766550.32248860.51920.784150.9095

Osteoporosisiv1980.63256520.32756720.41860.73080.8771

Anxiety/depression4v7170.66304170.3236740.45580.82650.9095

Respiratory Tract Diseasesiv2100.70757050.32781740.51920.82651

Digestive diseasesiv4810.73604240.30920.56980.86441

EQ-5D-Spanish TTO index score or tariff.

Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey

Table 4

Canary Island General population- EQ-5D-Spanish TTO Tariff

PopulationSampleAverageStandard deviationPercentile 25%Percentile 50%Percentile 75%
General population42820.85094470.24971440.826511

General population (men)17830.88828250.2242560.877111

General population(women)24990.82430460.26322070.78690.90951

General populationAge 16-4421400.92263520.16782220.909511

General populationAge 45-6411560.8241190.25723520.78690.90951

General populationAge ≥ 659860.72679930.32377080.59670.82651

General populationSeniors IAge 65-745980.77008430.28652730.70390.87711

General populationSeniors IIAge 75-843160.68226460.35207690.51920.82651

General populationSeniors IIIAge ≥ 85720.56275140.40265110.330450.65280.87985

Source: own elaboration from Canary Island Health Survey

Table 5

Canarian people that suffer a specific disease.

PopulationSampleAverageStandard deviationPercentile 25%Percentile 50%Percentile 75%
HIV+i51971.1425821.83456607590

 HIV-asymptomatic24974.4618521.20806608090

 HIV-symptomatic13366.6842124.70902557085

 AIDS13769.4379618.98795557080

Alzheimer diseaseii23740.9831219.47618304050

 AD mild4952.2040818.61449405060

 AD medium9142.802217.08165304550

 AD severe9733.6082519.06161203550

Strokeiii42353.6861826.28795355075

 Stroke survivor first year8955.9555626.62301406070

 Stroke survivor second year19351.6443327.04482305070

 Stroke survivor three or more years14155.0279724.98082405080

Diabetes Mellitusiv34247.8187127.34437305070

Rheumatism; arthritis; degenerative osteoarthritisiv95347.2812228.06338205070

Back painiv95650.9110929.65606255575

Heart problemsiv30847.3051927.43576205065

Osteoporosisiv19645.6173527.10741205070

Anxiety/depression4v67648.4319528.91151205070

Respiratory Tract Diseasesiv20249.9851528.27661305070

Digestive diseasesiv47450.3206830.08477105875

Visual Analogical Scale (thermometer).

Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey

Table 6

Canary Island general population

PopulationSampleAverageStandard deviationPercentile 25%Percentile 50%Percentile 75%
General population417659.312530.99565407080

General population (men)173964.6434729.17882507585

General population(women)243755.5084131.69165306080

General populationAge 16-44212865.0422931.28681508090

General populationAge 45-65113056.417730.0071406580

General populationAge ≥ 6591849.5936828.5296255070

General populationSeniors IAge 65-7456850.2764128.75174305570

General populationSeniors IIAge 75-8430049.1528.46545205570

General populationSeniors IIIAge ≥ 855044.526.25172205063

Visual Analogical Scale (thermometer)

Source: own elaboration from Canary Island Health Survey

Percentage of people that suffer a specific disease reporting moderate or severe problems in different Health Related Quality of Life dimensions Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey Canary Island General population-Percentage of people reporting moderate or severe problems in different Health Related Quality of Life dimensions Source: own elaboration from Canary Island Health Survey Canarian Population that suffer a specific disease. EQ-5D-Spanish TTO index score or tariff. Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey Canary Island General population- EQ-5D-Spanish TTO Tariff Source: own elaboration from Canary Island Health Survey Canarian people that suffer a specific disease. Visual Analogical Scale (thermometer). Sources: i Observational study on HIV/AIDS (19); ii Observational study on Alzheimer's disease (18); iii Observational study on Stroke (20); iv Canary Island Health Survey Canary Island general population Visual Analogical Scale (thermometer) Source: own elaboration from Canary Island Health Survey Depression/anxiety is the most affected dimension of HRQOL for HIV and anxiety/depression patients, representing a relative younger patient group. In the Alzheimer's disease (AD), the high percentage of moderate-severe problems stands out in each one of the five dimensions (5D), especially in usual activities and in self care, 95% and 85% respectively. Stroke patients also present high percentages of severe-moderate problem in all dimensions, over the 50% in most cases. Osteomuscular diseases (rheumatism; arthritis; degenerative osteoarthritis; osteoporosis and back pain) show a similar prevalence of severe-moderate problems in the five dimensions, being pain/discomfort the most problematic dimension in people that suffer these diseases. Regarding other studied diseases such as diabetes, heart problems, anxiety/depression, respiratory and digestive diseases, severe-moderate problems are mainly present in pain-discomfort and depression/anxiety dimensions. Focusing on disease progression, HIV and AD show a similar pattern: the higher the disease severity the higher the complications rate. However, the condition of patients who survive a stroke does not improve with time. On the contrary, the health status seems to get worse (see table 1). As expected, comparing the results of general population (see table 2) with the results obtained for people that suffer each specific disease, it can be observed a higher percentage of people reporting moderate or severe problems in different Health Related Quality of Life dimensions for all diseases than in general population (up to 10 percentage points in 4 of the 5 studied dimensions). Alzheimer's disease and Stroke patients suffer the highest loss in HRQOL, with differences exceeding 30 percentage points in 3 of the 5 dimensions. AD is the most remarkable case of HRQOL loss due to the existing differences between patients and general population, approximately 60 percentage points in self-care and usual activities. The percentage of people that survive a stroke reporting moderate or severe problems in different HRQOL dimensions is remarkable. Likewise, rheumatism and diabetes show differences in problems reported in the five dimensions of 10 percentage points. Digestive and heart problems present this type of differences in problems reported in 3 of the 5 dimensions. People that suffer other diseases reported lower differences in moderate or severe problems in HRQOL dimensions compared with the general population. The most discouraging results in percentile analysis correspond to AD. Table 3 shows that the best group of AD patients, percentile 75, has a low TTO value, 0.3388, and this index score or tariff takes a negative value in percentiles 25. Stroke results show that some patients in the percentile 75 almost recover the normal QOL after stroke; however, a considerable number of patients (percentiles 50 and 25), suffered severe consequences after the cerebrovascular accident. HIV/AIDS results are fairly better compared with other diseases. In the other diseases, we observe a progressive loss of QOL compared to general population, that is, that percentile 75 shows a similar behaviour, whereas percentile 25 has values that are slightly lower. On the one hand, percentile 75 of HIV, diabetes, back pain, respiratory and digestive disease seems to have a similar QOL compared to general population. On the other hand, rheumatism, heart problems, osteoporosis and anxiety have after-effects and show differences of about a 10 percentage points in percentile 75 (see tables 3 and 4). Results obtained by VAS method for specific diseases and general population are similar to TTO ones (see tables 5 and 6). AD has again the lowest values in VAS results but these numbers are higher than those obtained by TTO method for AD. This situation recurs in the stroke case. In the case of anxiety/depression, back pain and rheumatism, the loss of QOL is progressive; that is, there is small differences between QOL of general population and people with specific diseases who reported better health status (up to 5-10 points approximately in percentile 75) and this difference increases in people who reported worse health status (up to 15-20 points in percentile 25). Osteoporosis shows also a progressive pattern with a slight difference, a group of patients, percentile 75, maintain the QOL of general population. Percentile 75 and 50 of digestive disease show that an important number of patients that almost maintain a normal life, whereas patients in percentile 25 suffer severe consequences. Diabetes, heart problems and respiratory diseases patients have a loss of QOL that is constant across the percentile analysis, or slightly increases in percentile 25.

Discussion and conclusions

Over the years, there has been a progressive interest in listening user's and citizens' voice in different aspects of the delivery of health services. The identification and assessment of HRQOL of patients and the general population are a promising way of achieving this goal. Health surveys offer the opportunity to monitor population's health problems by means of validated instruments and to assess its potential impact on HRQOL. From a public health perspective, such monitoring allows the identification of potential changes in prevalence and inequalities on health status, and reveals unmet needs in the community [27]. The impact of health state changes on an individual's quality of life has gained increased attention in social and medical clinical research [28]. There is an extended acknowledgement that "classic" measurement of health as expectancy of life and morbidity rates should be complemented, especially in developed countries with a high and increasing prevalence of chronic conditions, by Health Related Quality of Life measurements. The Canary Island Health Survey gives an overview of the Canary citizens' health status to joining two types of indicators: self perceived health status (HRQOL) and chronic conditions (self-reported, but based on known medical diagnosis). However, this useful information should be complemented with "ad hoc" studies focused on diseases with strong health and social impact but low rates of prevalence. In this work, we show that depression/anxiety and pain/discomfort are the most affected dimensions in the Canary population that suffer a chronic disease. The progression pattern observed is the higher severity of disease higher probability of reporting moderate or severe problems in different HRQOL dimensions, with the exception of stroke patients that don't seem to improve with the passage of time. The HRQOL monitoring in the general population requires generic instruments that ideally capture all-important aspects of self perceived health, allowing comparisons within and between populations. The combination of EQ-5 D with any other specific scales should be carefully considered. Specific measurements bring into focus the burden on health and functioning for a health condition or treatment. Generic HRQOL measurements are intended to provide information on general function and well-being with the advantage of allowing comparisons among different diseases or populations. Besides EQ-5 D can be used to estimate and compare self-perceived effectiveness and cost-effectiveness of different health care interventions intended to improve populations' health [29-31]. Hence, the EQ-5 D is one of the instruments most frequently used in cost utility analysis for the development of QALYs in the field of Health Technology Assessment [31]. Although some countries have expressed criticism of the use of QALYs in economic evaluation [32,33], the outcome remains the most demanded by the rating agencies of health interventions in most European countries [34-39]. In this sense, the measurement of populations' HRQOL from a country or region and the study of its evolution can be a useful tool for decision-makers. Self perceived health status can contribute to complement the information reported by life expectancy and incidence and prevalence morbidity indicators. A complete description on the health status of citizens can help to an efficient allocation of health care and social resources in order to satisfy the social needs. Besides, having a synthetic indicator that combine expectancy and quality of life make easier the comparison between costs and consequences of implementing health policies. For instance, policies to prevent infant obesity, restrictive laws on tobacco and alcohol consumption, the implementation of integrated programmes on Ischemic Heart Diseases, Tumours, Stroke, Mental Illness, Diabetes Mellitus, or the expansion of another preventive programs, only for mentioning some of the most recent health policies promoted by the Spanish Ministry of Health and Social Policy jointly with regional authorities. So, the measurement of self-perceived health of the population using multidimensional concepts should be considered as a relevant part of the development of methods and tools that could help to a better understanding of the effectiveness of health care services and to a more appropriated valuation of the returns of the health care systems. Certain limitations of this study should be discussed. First, like most other studies on general population, our analysis does not include institutionalized people. Second, it can be argued that data on HRQOL are self-reported and that fact limits its validity. However, HRQOL is the way of getting information on subjective aspects of health. So, as Sullivan (2003) [1] note "...patient outcomes... are valid because they are subjective". Third, illnesses were self-reported in CIHS. Although, other studies show evidence of good agreement between self-reporting and clinical diagnoses of chronic diseases [40-42], the replies of people that had been diagnosed can be affected by the accessibility or availability of medical services when they were asked about their diseases, . In second place, we have performed a descriptive study instead of developing a statistical model that helping to explain differences in HRQOL between individuals. Unfortunately, we do not have a collection of same explanatory variables in the observational studies and CIHS. Only age and sex/gender and diagnosed diseases could have been used in this analysis. For this reason, at the moment, we considered more interesting to show, in a descriptive way, the HRQOL of people that suffer a chronic disease in comparison with general population. Other studies analyzed the association between HRQOL and socioeconomic health determinants in Canary Island [43] using more sophisticated statistical techniques [43]. Finally, the different data sources evaluated in the paper were developed at different time frames. Positive, or negative, changes in health habits trends and the introduction of new health care technologies can improve, or worse, the health status of population and the self perceived health status of people that suffer a certain disease. However, in our study the differences between the dates where studies and Canary Island Health Survey were developed are small, from 2001 to 2004, and we would not expect sharp change in self perceived health status of people that suffer a certain disease. Despite these limitations, this study shows a remarkable loss of HRQOL in people that suffer a chronic disease compared to general population. These findings stress the importance of disease prevention interventions as well as the early detection (screening) and efficient management of chronic conditions, in order to improve HRQOL. Future research is needed for improving our knowledge about explanatory variables that affect the HRQOL of people along their lifetime.

Abbreviations

5D: Five dimensions; AD: Alzheimer's disease; AIDS: Acquired immune deficiency syndrome; CDC: Center of Disease Control and Prevention; CDR: Clinical Dementia Rating; CIHS: Canary Island Health Survey; HIV: Human Immunodeficiency Virus; HRQOL: Health-related Quality of Life; QOL: Quality of Life; TTO: Time Trade-Off; VAS: Visual Analogue Scale.

Competing interests

The authors declare that they have no competing interest.

Authors' contributions

JOM and JLB contributed to the design of the study, analysis of the results and writing of the manuscript. MWC contributed to the analysis of the results and writing of the manuscript. PSA contributed to the design of the study and writing of the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/10/675/prepub
  37 in total

1.  Prioritizing investments in health technology assessment. Can we assess potential value for money?

Authors:  L Davies; M Drummond; P Papanikolaou
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

2.  A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states.

Authors:  X Badia; M Roset; M Herdman; P Kind
Journal:  Med Decis Making       Date:  2001 Jan-Feb       Impact factor: 2.583

Review 3.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

4.  Health technology assessment for medical devices in Europe. What must be considered.

Authors:  Markus Siebert; Louis Christian Clauss; Malcolm Carlisle; Brigitte Casteels; Peter de Jong; Michael Kreuzer; Sukh Sanghera; Graham Stokoe; Paul Trueman; Antoinette Wenk Lang
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

5.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

6.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

7.  Self-report and medical record report agreement of selected medical conditions in the elderly.

Authors:  T L Bush; S R Miller; A L Golden; W E Hale
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

8.  Using multidimensional health measures in older persons to identify risk of hospitalization and skilled nursing placement.

Authors:  A L Siu; D B Reuben; J G Ouslander; D Osterweil
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

9.  The new subjective medicine: taking the patient's point of view on health care and health.

Authors:  Mark Sullivan
Journal:  Soc Sci Med       Date:  2003-04       Impact factor: 4.634

10.  Health perceptions of primary care patients and the influence on health care utilization.

Authors:  J E Connelly; J T Philbrick; G R Smith; D L Kaiser; A Wymer
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

View more
  12 in total

1.  Cost-utility analysis of gastric bypass for severely obese patients in Spain.

Authors:  Iván Castilla; Javier Mar; Cristina Valcárcel-Nazco; Arantzazu Arrospide; Juan M Ramos-Goñi
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

Review 2.  Tools used for evaluation of Brazilian children's quality of life.

Authors:  João Gabriel S Souza; Marcela Antunes Pamponet; Tamirys Caroline S Souza; Alessandra Ribeiro Pereira; Andrey George S Souza; Andréa Maria E de B L Martins
Journal:  Rev Paul Pediatr       Date:  2014-06

3.  Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain.

Authors:  Javier Mar; Jaime Masjuan; Juan Oliva-Moreno; Nuria Gonzalez-Rojas; Virginia Becerra; Miguel Ángel Casado; Covadonga Torres; María Yebenes; Manuel Quintana; Jose Alvarez-Sabín
Journal:  Health Qual Life Outcomes       Date:  2015-03-17       Impact factor: 3.186

Review 4.  Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis.

Authors:  Bach Xuan Tran; Long Hoang Nguyen; Arto Ohinmaa; Rachel Marie Maher; Vuong Minh Nong; Carl A Latkin
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

5.  Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.

Authors:  Julio López-Bastida; Luz María Peña-Longobardo; Isaac Aranda-Reneo; Eduardo Tizzano; Mark Sefton; Juan Oliva-Moreno
Journal:  Orphanet J Rare Dis       Date:  2017-08-18       Impact factor: 4.123

6.  Health-related quality of life and long-term care needs among elderly individuals living alone: a cross-sectional study in rural areas of Shaanxi Province, China.

Authors:  Ning Liu; Lingxia Zeng; Zhe Li; Jue Wang
Journal:  BMC Public Health       Date:  2013-04-08       Impact factor: 3.295

7.  Costs, outcomes and challenges for diabetes care in Spain.

Authors:  Julio Lopez-Bastida; Mauro Boronat; Juan Oliva Moreno; Willemien Schurer
Journal:  Global Health       Date:  2013-05-01       Impact factor: 4.185

8.  Health-related quality of life and preferred health-seeking institutions among rural elderly individuals with and without chronic conditions: a population-based study in Guangdong Province, China.

Authors:  Zhiheng Zhou; Caixia Wang; Huajie Yang; Xiang Wang; Chanjiao Zheng; Jiaji Wang
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

9.  Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.

Authors:  Arantzazu Arrospide; Montserrat Rue; Nicolien T van Ravesteyn; Merce Comas; Myriam Soto-Gordoa; Garbiñe Sarriugarte; Javier Mar
Journal:  BMC Cancer       Date:  2016-06-01       Impact factor: 4.430

10.  Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.

Authors:  J Lopez-Bastida; I Aranda-Reneo; B Rodríguez-Sánchez; L M Peña-Longobardo; X Ye; P Laeis; E M Fronk; E Palmerini; A Leithner; M A J Van de Sande
Journal:  Orphanet J Rare Dis       Date:  2021-07-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.